Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 8, 2019updated 10 Jan 2019 9:40am

PCI to expand clinical and commercial packaging capabilities

PCI Pharma Services is investing more than $20m to expanded Biotech clinical and commercial packaging and release testing capabilities at its centre of excellence in Philadelphia, US.

PCI Pharma Services is investing more than $20m to expanded Biotech clinical and commercial packaging and release testing capabilities at its centre of excellence in Philadelphia, US.

The move will support its biologic medicines and advanced injectable delivery forms.

PCI will use the investment to expand the labelling and assembly of safety syringes, autoinjector and pen devices with integrated high-speed cartoning, in-line serialisation, as well as its onsite cold chain storage.

PCI CEO Salim Haffar said: “I am pleased to share this news regarding our continued investment to support the needs of our biotech customers.

“We are proud to be the partner of choice for drug development companies as they look to outsource these specialised requirements for clinical and commercial packaging.

“These investments demonstrate our commitment to bringing lifesaving medicines to patients around the world.”

Content from our partners
GMP: The food sector’s golden rules (and how they will evolve)
Food fraud in the supply chain (and how to fix it)
Cutting-edge innovation in fish packaging

PCI offers clinical and commercial packaging services of various delivery forms such as injectables, topicals, transdermals and solid oral dose.

“These investments demonstrate our commitment to bringing lifesaving medicines to patients around the world.”

The company’s injectable delivery form capabilities include ampoules, vials, cartridges and standard prefilled syringes, advanced safety syringes, autoinjectors and pen devices.

It currently operates facilities in the US, the UK, Europe, and Australia, to serve its customers across more than 100 countries globally.

In October, PCI completed the acquisition of Sherpa Clinical Packaging in a move to expand its clinical services network to California, US.

The acquisition represents complementary packaging, labelling, distribution, temperature-controlled storage and returns services.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The packaging industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU